Iterum Therapeutics Plc (ITRM)
0.2239
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 13:43
Iterum Therapeutics EPS Diluted (Quarterly) : -0.196 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3701 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Prothena Corp. Plc | -0.6788 |
| GH Research Plc | -0.226 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.979M |
| Revenue (Quarterly) | 0.39M |
| Total Expenses (Quarterly) | 9.369M |
| Enterprise Value | 32.60M |
| Gross Profit Margin (Quarterly) | 3.85% |
| Profit Margin (Quarterly) | -2.30K% |
| Earnings Yield | -334.6% |
| Normalized Earnings Yield | -296.52 |